Skip to content

APVO APTEVO THERAPEUTICS INC

Follow

COM (common), issuer CIK 1671584

Filings received so far for Q3 2026: 11 13F filers report a position in APVO shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
SABBY MANAGEMENT, LLC232,692$423K6.33%new13F-HRTimeline
Hudson Bay Capital Management LPin group Hudson Bay Capital Management…40,700$74.1K<0.01%new13F-HRTimelineGroup
CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC25,171$45.8K<0.01%new13F-HRTimelineGroup
GSA CAPITAL PARTNERS LLP21,539$39K<0.01%013F-HRTimeline
VANGUARD GROUP INCgroup of 2 filers holding16,855$30.7K0Timeline
Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T…1,911$3.48K<0.01%new13F-HRTimelineGroup
OSAIC HOLDINGS, INC.in group OSAIC HOLDINGS, INC.360$664<0.01%013F-HRTimelineGroup
SBI Securities Co., Ltd.105$191<0.01%-413F-HRTimeline
Caitong International Asset Management …3$5<0.01%new13F-HRTimeline
DANSKE BANK A/S1$2<0.01%013F-HRTimeline

Events

  • CVI Investments, Inc. and 1 other reporting person reported 83,854 APVO shares, 4.4% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001649553-26-000140

    Accepted , ingested
  • Ayrton Capital LLC and 2 other reporting persons reported 69,965 APVO shares, 3.72% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-12. 0001493152-26-051277

    Accepted , ingested